Advertisement
BAC vs CDC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAC is a StrongBuy and CDC is a StrongBuy.
BAC's RSI Oscillator ascending out of oversold territory
The RSI Oscillator for BAC moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 25 of the 32 cases the stock moved higher. This puts the odds of a move higher at 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on BAC as a result. In 53 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for BAC just turned positive on October 26, 2026. Looking at past instances where BAC's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
Following a +2.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAC advanced for three days, in 212 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
BAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Aroon Indicator for BAC entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 2 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.252) is normal, around the industry mean (1.500). P/E Ratio (11.232) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (0.873) is also within normal values, averaging (2.139). Dividend Yield (0.026) settles around the average of (0.035) among similar stocks. P/S Ratio (3.643) is also within normal values, averaging (3.867).
The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock slightly worse than average.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. BAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
CDC in upward trend: price rose above 50-day moving average on October 20, 2026
CDC moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 43 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CDC as a result. In 70 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for CDC just turned positive on October 07, 2026. Looking at past instances where CDC's MACD turned positive, the stock continued to rise in 45 of 53 cases over the following month. The odds of a continued upward trend are 85%.
The 10-day moving average for CDC crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +1.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where CDC advanced for three days, in 269 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 280 of 364 cases where CDC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
Bearish Trend Analysis
The 10-day RSI Indicator for CDC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 27 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 66 cases where CDC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
CDC broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
BAC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 60 | |
SMR RATING 1..100 | 2 | |
PRICE GROWTH RATING 1..100 | 61 | |
P/E GROWTH RATING 1..100 | 75 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BAC | CDC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 78% | 2 days ago 87% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 62% |
| Momentum ODDS (%) | 2 days ago 72% | 3 days ago 79% |
| MACD ODDS (%) | 2 days ago 70% | 6 days ago 85% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 56% | 2 days ago 77% |
| Advances ODDS (%) | 2 days ago 62% | 2 days ago 78% |
| Declines ODDS (%) | 6 days ago 62% | 6 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 64% | 2 days ago 77% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAC’s FA Score shows that 1 FA rating(s) are green while .
- BAC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAC’s TA Score shows that 6 TA indicator(s) are bullish.
- BAC’s TA Score: 6 bullish, 2 bearish.
Price Growth
BAC (@Major Banks) experienced а +2.05% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Major Banks industry was -0.74%. For the same industry, the average monthly price growth was +1.49%, and the average quarterly price growth was +11.62%.
Reported Earning Dates
BAC is expected to report earnings on Jan 15, 2027.
Industries' Descriptions
@Major Banks (-0.74% weekly)Major banks are among the biggest companies in the world, often times with global reach and market capitalizations in the multi-billions. Large banks often have multiple arms spanning different disciplines, from deposits, to investment banking, to wealth management and insurance. The biggest banks often have key competitive advantages over smaller players in the industry in terms of brand recognition, cost of capital, and efficiency. Think J.P. Morgan, Bank of America, Wells Fargo, and Citigroup.
Advertisement
CDC and
Correlation & Price change
A.I.dvisor indicates that over the last year, CDC has been closely correlated with LNT. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDC jumps, then LNT could also see price increases.